Baxter International BAX Healthcare Systems & Technologies — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's healthcare systems & technologies — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Baxter International's healthcare systems & technologies — net sales?
- Baxter International (BAX) reported healthcare systems & technologies — net sales of $705M in Q1 2026.
- How has Baxter International's healthcare systems & technologies — net sales changed year-over-year?
- Baxter International's healthcare systems & technologies — net sales increased by 0.1% year-over-year, from $704M to $705M.
- What is the long-term trend for Baxter International's healthcare systems & technologies — net sales?
- Over 3 years (2021 to 2025), Baxter International's healthcare systems & technologies — net sales has grown at a 143.8% compound annual growth rate (CAGR), from $212M to $3.07B.
- What does healthcare systems & technologies — net sales mean?
- Total revenue earned from selling products in this business segment after accounting for returns and discounts.
- How do you interpret healthcare systems & technologies — net sales?
- Higher sales indicate strong market adoption and effective commercial execution.
- How does healthcare systems & technologies — net sales compare across companies?
- Benchmark against other medical technology segments focusing on hospital capital equipment.